Other substances

[(2S,4R)-4-Hydroxy-2-methoxy-5-[(2S)-6-oxo-2,3-dihydropyran-2-yl]pentyl] 5-oxo-5-[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]pentanoate

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

[(2S,4R)-4-Hydroxy-2-methoxy-5-[(2S)-6-oxo-2,3-dihydropyran-2-yl]pentyl] 5-oxo-5-[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]pentanoate on PubChem

Synonyms

CHEMBL3393617; 118,725,563

 

Structure image - [(2S,4R)-4-Hydroxy-2-methoxy-5-[(2S)-6-oxo-2,3-dihydropyran-2-yl]pentyl] 5-oxo-5-[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]pentanoate

COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(=C(C(=C32)OC)OC)OC)NC(=O)CCCC(=O)OC[C@H](C[C@@H](C[C@@H]4CC=CC(=O)O4)O)OC

Supporting references

Link Tested on Impact factor Notes Publication date
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
Membrane protein Small molecule In silico 		in silico 3.00

Predicted to bind SARS-CoV-2 Membrane protein.

 Mar/05/2021
Export (.csv)